87 related articles for article (PubMed ID: 19769577)
1. Pp IX silica nanoparticles demonstrate differential interactions with in vitro tumor cell lines and in vivo mouse models of human cancers.
Simon V; Devaux C; Darmon A; Donnet T; Thiénot E; Germain M; Honnorat J; Duval A; Pottier A; Borghi E; Levy L; Marill J
Photochem Photobiol; 2010; 86(1):213-22. PubMed ID: 19769577
[TBL] [Abstract][Full Text] [Related]
2. One pot synthesis of new hybrid versatile nanocarrier exhibiting efficient stability in biological environment for use in photodynamic therapy.
Thienot E; Germain M; Piejos K; Simon V; Darmon A; Marill J; Borghi E; Levy L; Hochepied JF; Pottier A
J Photochem Photobiol B; 2010 Jul; 100(1):1-9. PubMed ID: 20456971
[TBL] [Abstract][Full Text] [Related]
3. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic application of protoporphyrin IX as a photosensitizer encapsulated by silica nanoparticles.
Makhadmeh GN; Abdul Aziz A
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1043-S1046. PubMed ID: 30449196
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
6. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy.
Qian J; Gharibi A; He S
J Biomed Opt; 2009; 14(1):014012. PubMed ID: 19256700
[TBL] [Abstract][Full Text] [Related]
7. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
[TBL] [Abstract][Full Text] [Related]
8. pH-responsive
Namulinda T; Yan YJ; Wang LH; Qiu Y; Jin H; Kwetegyeka J; Gumula I; Atassi Y; Karam S; Chen ZL
Nanomedicine (Lond); 2024 Jan; 19(2):127-143. PubMed ID: 38131290
[TBL] [Abstract][Full Text] [Related]
9. Hollow silica nanoparticles loaded with hydrophobic phthalocyanine for near-infrared photodynamic and photothermal combination therapy.
Peng J; Zhao L; Zhu X; Sun Y; Feng W; Gao Y; Wang L; Li F
Biomaterials; 2013 Oct; 34(32):7905-12. PubMed ID: 23891514
[TBL] [Abstract][Full Text] [Related]
10. A redox-responsive mesoporous silica based nanoplatform for in vitro tumor-specific fluorescence imaging and enhanced photodynamic therapy.
Yuan F; Li JL; Cheng H; Zeng X; Zhang XZ
Biomater Sci; 2017 Dec; 6(1):96-100. PubMed ID: 29186237
[TBL] [Abstract][Full Text] [Related]
11. Silica-based nanoparticles for photodynamic therapy applications.
Couleaud P; Morosini V; Frochot C; Richeter S; Raehm L; Durand JO
Nanoscale; 2010 Jul; 2(7):1083-95. PubMed ID: 20648332
[TBL] [Abstract][Full Text] [Related]
12. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
13. A spectroscopic study of the photobleaching of protoporphyrin IX in solution.
Ericson MB; Grapengiesser S; Gudmundson F; Wennberg AM; Larkö O; Moan J; Rosén A
Lasers Med Sci; 2003; 18(1):56-62. PubMed ID: 12627275
[TBL] [Abstract][Full Text] [Related]
14. Protoporphyrin IX nanoparticle carrier: preparation, optical properties, and singlet oxygen generation.
Rossi LM; Silva PR; Vono LL; Fernandes AU; Tada DB; Baptista MS
Langmuir; 2008 Nov; 24(21):12534-8. PubMed ID: 18834155
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging.
Qian J; Wang D; Cai F; Zhan Q; Wang Y; He S
Biomaterials; 2012 Jun; 33(19):4851-60. PubMed ID: 22484045
[TBL] [Abstract][Full Text] [Related]
16. Diamino acid derivatives of PpIX as potential photosensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: in vitro studies.
Kwitniewski M; Juzeniene A; Ma LW; Glosnicka R; Graczyk A; Moan J
J Photochem Photobiol B; 2009 Mar; 94(3):214-22. PubMed ID: 19136276
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy.
Ma X; Qu Q; Zhao Y
ACS Appl Mater Interfaces; 2015 May; 7(20):10671-6. PubMed ID: 25974979
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin.
Kwitniewski M; Jankowski D; Jaskiewicz K; Dziadziuszko H; Juzeniene A; Moan J; Ma LW; Peksa R; Kunikowska D; Graczyk A; Kwasny M; Kaliszewski M; Glosnicka R
Int J Cancer; 2009 Oct; 125(7):1721-7. PubMed ID: 19521986
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy.
He X; Wu X; Wang K; Shi B; Hai L
Biomaterials; 2009 Oct; 30(29):5601-9. PubMed ID: 19595455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
